Related references
Note: Only part of the references are listed.The Epidemiology and Clinical Features of Balamuthia mandrillaris Disease in the United States, 1974-2016
Jennifer R. Cope et al.
CLINICAL INFECTIOUS DISEASES (2019)
AIDS Presenting as Granulomatous Amebic Encephalitis: PET and MR Imaging correlation
Joshua D. Dowell et al.
JOURNAL OF NEUROIMAGING (2015)
Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris
Huma Kulsoom et al.
EXPERIMENTAL PARASITOLOGY (2014)
Successful Treatment of Granulomatous Amoebic Encephalitis with Combination Antimicrobial Therapy
Hideki Kato et al.
INTERNAL MEDICINE (2013)
Case Report: Treatment of Granulomatous Amoebic Encephalitis with Voriconazole and Miltefosine in an Immunocompetent Soldier
Duncan Webster et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Central Nervous System Infection
Ashley H. Aiken
NEUROIMAGING CLINICS OF NORTH AMERICA (2010)
Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri
Yvonne Qvarnstrom et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis
FL Schuster et al.
CLINICAL INFECTIOUS DISEASES (2006)
In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas:: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri
FL Schuster et al.
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2006)
Acanthamoeba spp. as agents of disease in humans
F Marciano-Cabral et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
Share Paper
